Minimally Invasive Medicine (00853) fell by more than 5%. As of press release, it fell 4.84% to HK$5.5, with a turnover of HK$28.9347 million.
The Zhitong Finance App learned that Minimally Invasive Healthcare (00853) fell by more than 5%. As of press release, it fell 4.84% to HK$5.5, with a turnover of HK$28.9347 million.
According to the news, on April 5, Minimally Invasive Healthcare issued an announcement stating that the company has obtained a financing of up to 200 million US dollars from institutions such as Gao Lin Capital and will obtain a loan of 300 million US dollars to repay the 448 million US dollars convertible bonds that are about to expire.
Nomura pointed out that the exercise price of US$150 million was HK$7.46, and the company must meet its performance targets. Otherwise, it will be necessary to repay the $50 million loan from High House Capital in advance. The bank believes that the situation may improve in the short term, but it will still be difficult in the long run. As a result, the target price for minimally invasive medicine was lowered from HK$7.19 to HK$6.71, giving it a “neutral” rating.